A comprehensive view of Eye Drops. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Brassica Pharma recalls eye ointment products sold at CVS and Walmart due to potential risk of infection after FDA cites lack of sterility assurance at manufacturing facility; no adverse reports received as of February 16
Published:
March 01, 2024
by WITI-TV (Milwaukee, WI)
|
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris, including 10mm child-resistant tube, Twist’n’Use Soft Long Nozzle small-diameter tube, SteriDrop tube for preservative-free eyedrops, and reduced material LowPro Caps
Published:
January 31, 2024
by WhatTheyThink
|
FDA seeks new powers from Congress to ensure quality of OTC eyedrops amidst concerns over unsanitary manufacturing conditions abroad and lack of foreign inspections
Published:
December 28, 2023
by Associated Press
|
FDA's recall of eye drops from leading retailers due to violations of sterility regulations at Kilitch Healthcare India's facility in Navi Mumbai; FDA cites numerous violations at the plant
Published:
November 16, 2023
by McClatchy Washington Bureau (DC)
|
FDA recalls 27 additional eye drop products including CVS Health, Rite Aid, and Walmart brands due to potential safety concerns, following discovery of insanitary conditions; manufacturer Kilitch Healthcare India to voluntarily recall all affected lots
Published:
November 16, 2023
by USA Today Online
|
Ask us about our Tissue & Hygiene market view